Recent advances in antibiotics
The most important of the recent advances in antibiotics has been the development of the semi-synthetic penicillins, since all the penicillins possess the inherent advantages of a bactericidal action and virtual lack of toxicity.
Gespeichert in:
| Veröffentlicht in: | South African medical journal 1969-03, Vol.43 (11), p.311-316 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 316 |
|---|---|
| container_issue | 11 |
| container_start_page | 311 |
| container_title | South African medical journal |
| container_volume | 43 |
| creator | Charlton, R.W. |
| description | The most important of the recent advances in antibiotics has been the development of the semi-synthetic penicillins, since all the penicillins possess the inherent advantages of a bactericidal action and virtual lack of toxicity. |
| format | Article |
| fullrecord | <record><control><sourceid>sabinet_JRA</sourceid><recordid>TN_cdi_pubmed_primary_4305557</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sabinet_id>10520/AJA20785135_35799</sabinet_id><sourcerecordid>10520/AJA20785135_35799</sourcerecordid><originalsourceid>FETCH-LOGICAL-p919-f14626cca881e891b71d7253d9c1b485ef825ab601cddee4577cf6f4ef7218173</originalsourceid><addsrcrecordid>eNotj9tKAzEYhIModa0-grIvEMjpz-FyKR4pCNL7kMMfiNh1aVbBt3dLezUM3zDMXJBOMGMpcAmXpGMCNHVg1DW5ae2TLR6cXpGVkgwATEcePjDhOPch_4YxYevr2IdxrrF-zzW1W3JVwlfDu7Ouye7pcbd5odv359fNsKWT444WrrTQKQVrOVrHo-HZCJDZJR6VBSxWQIia8ZQzogJjUtFFYTGCW27kmtyfaqefuMfsp0Pdh8OfP89cOD3xFmIdcfYt4BL1nIFgfngbjqePn70E45z8BzCuRfY</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Recent advances in antibiotics</title><source>Sabinet African Journals Open Access Collection</source><creator>Charlton, R.W.</creator><creatorcontrib>Charlton, R.W.</creatorcontrib><description>The most important of the recent advances in antibiotics has been the development of the semi-synthetic penicillins, since all the penicillins possess the inherent advantages of a bactericidal action and virtual lack of toxicity.</description><identifier>ISSN: 0256-9574</identifier><identifier>EISSN: 2078-5135</identifier><identifier>PMID: 4305557</identifier><language>eng</language><publisher>South Africa: Health and Medical Publishing Group (HMPG)</publisher><subject>Anti-Bacterial Agents - administration & dosage ; Anti-Bacterial Agents - adverse effects ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Antifungal Agents - therapeutic use ; Bacteriology ; Cephaloridine - therapeutic use ; Chloramphenicol - therapeutic use ; Colistin - therapeutic use ; Erythromycin - therapeutic use ; Fusidic Acid - therapeutic use ; Gentamicins - therapeutic use ; Humans ; Kanamycin - therapeutic use ; Lincomycin - therapeutic use ; Neomycin - therapeutic use ; Novobiocin - therapeutic use ; Paromomycin - therapeutic use ; Penicillins - therapeutic use ; Pharmacology ; Polymyxins - therapeutic use ; Recent advances ; Streptomycin - therapeutic use ; Tetracycline - adverse effects ; Tetracycline - therapeutic use</subject><ispartof>South African medical journal, 1969-03, Vol.43 (11), p.311-316</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,39242</link.rule.ids><linktorsrc>$$Uhttp://hdl.handle.net/10520/AJA20785135_35799$$EView_record_in_Sabinet_Online_Ltd.$$FView_record_in_$$GSabinet_Online_Ltd.</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/4305557$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Charlton, R.W.</creatorcontrib><title>Recent advances in antibiotics</title><title>South African medical journal</title><addtitle>S Afr Med J</addtitle><description>The most important of the recent advances in antibiotics has been the development of the semi-synthetic penicillins, since all the penicillins possess the inherent advantages of a bactericidal action and virtual lack of toxicity.</description><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Bacteriology</subject><subject>Cephaloridine - therapeutic use</subject><subject>Chloramphenicol - therapeutic use</subject><subject>Colistin - therapeutic use</subject><subject>Erythromycin - therapeutic use</subject><subject>Fusidic Acid - therapeutic use</subject><subject>Gentamicins - therapeutic use</subject><subject>Humans</subject><subject>Kanamycin - therapeutic use</subject><subject>Lincomycin - therapeutic use</subject><subject>Neomycin - therapeutic use</subject><subject>Novobiocin - therapeutic use</subject><subject>Paromomycin - therapeutic use</subject><subject>Penicillins - therapeutic use</subject><subject>Pharmacology</subject><subject>Polymyxins - therapeutic use</subject><subject>Recent advances</subject><subject>Streptomycin - therapeutic use</subject><subject>Tetracycline - adverse effects</subject><subject>Tetracycline - therapeutic use</subject><issn>0256-9574</issn><issn>2078-5135</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1969</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNotj9tKAzEYhIModa0-grIvEMjpz-FyKR4pCNL7kMMfiNh1aVbBt3dLezUM3zDMXJBOMGMpcAmXpGMCNHVg1DW5ae2TLR6cXpGVkgwATEcePjDhOPch_4YxYevr2IdxrrF-zzW1W3JVwlfDu7Ouye7pcbd5odv359fNsKWT444WrrTQKQVrOVrHo-HZCJDZJR6VBSxWQIia8ZQzogJjUtFFYTGCW27kmtyfaqefuMfsp0Pdh8OfP89cOD3xFmIdcfYt4BL1nIFgfngbjqePn70E45z8BzCuRfY</recordid><startdate>19690315</startdate><enddate>19690315</enddate><creator>Charlton, R.W.</creator><general>Health and Medical Publishing Group (HMPG)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>19690315</creationdate><title>Recent advances in antibiotics</title><author>Charlton, R.W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p919-f14626cca881e891b71d7253d9c1b485ef825ab601cddee4577cf6f4ef7218173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1969</creationdate><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Bacteriology</topic><topic>Cephaloridine - therapeutic use</topic><topic>Chloramphenicol - therapeutic use</topic><topic>Colistin - therapeutic use</topic><topic>Erythromycin - therapeutic use</topic><topic>Fusidic Acid - therapeutic use</topic><topic>Gentamicins - therapeutic use</topic><topic>Humans</topic><topic>Kanamycin - therapeutic use</topic><topic>Lincomycin - therapeutic use</topic><topic>Neomycin - therapeutic use</topic><topic>Novobiocin - therapeutic use</topic><topic>Paromomycin - therapeutic use</topic><topic>Penicillins - therapeutic use</topic><topic>Pharmacology</topic><topic>Polymyxins - therapeutic use</topic><topic>Recent advances</topic><topic>Streptomycin - therapeutic use</topic><topic>Tetracycline - adverse effects</topic><topic>Tetracycline - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Charlton, R.W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>South African medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Charlton, R.W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recent advances in antibiotics</atitle><jtitle>South African medical journal</jtitle><addtitle>S Afr Med J</addtitle><date>1969-03-15</date><risdate>1969</risdate><volume>43</volume><issue>11</issue><spage>311</spage><epage>316</epage><pages>311-316</pages><issn>0256-9574</issn><eissn>2078-5135</eissn><abstract>The most important of the recent advances in antibiotics has been the development of the semi-synthetic penicillins, since all the penicillins possess the inherent advantages of a bactericidal action and virtual lack of toxicity.</abstract><cop>South Africa</cop><pub>Health and Medical Publishing Group (HMPG)</pub><pmid>4305557</pmid><tpages>6</tpages></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | ISSN: 0256-9574 |
| ispartof | South African medical journal, 1969-03, Vol.43 (11), p.311-316 |
| issn | 0256-9574 2078-5135 |
| language | eng |
| recordid | cdi_pubmed_primary_4305557 |
| source | Sabinet African Journals Open Access Collection |
| subjects | Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibiotics Antifungal Agents - therapeutic use Bacteriology Cephaloridine - therapeutic use Chloramphenicol - therapeutic use Colistin - therapeutic use Erythromycin - therapeutic use Fusidic Acid - therapeutic use Gentamicins - therapeutic use Humans Kanamycin - therapeutic use Lincomycin - therapeutic use Neomycin - therapeutic use Novobiocin - therapeutic use Paromomycin - therapeutic use Penicillins - therapeutic use Pharmacology Polymyxins - therapeutic use Recent advances Streptomycin - therapeutic use Tetracycline - adverse effects Tetracycline - therapeutic use |
| title | Recent advances in antibiotics |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T02%3A18%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sabinet_JRA&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recent%20advances%20in%20antibiotics&rft.jtitle=South%20African%20medical%20journal&rft.au=Charlton,%20R.W.&rft.date=1969-03-15&rft.volume=43&rft.issue=11&rft.spage=311&rft.epage=316&rft.pages=311-316&rft.issn=0256-9574&rft.eissn=2078-5135&rft_id=info:doi/&rft_dat=%3Csabinet_JRA%3E10520/AJA20785135_35799%3C/sabinet_JRA%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/4305557&rft_sabinet_id=10520/AJA20785135_35799&rfr_iscdi=true |